|
|
|
|
Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HCV Coinfected Patients
|
|
|
Reported by Jules Levin
IDSA 2015 Oct 7-11 San Diego, CA
S Naggie1, C Cooper2, P Kwo3, K Kowdley4, S Naik5, M Natha5, LM Stamm5, PS Pang5, Mark Sulkowski6
1Duke Clinical Research Institute, Infectious Diseases Research, Durham, NC; 2The Ottawa Hospital and Regional Hepatitis Program, Ottawa, ON; 3Indiana University, Division of Gastroenterology/Hepatology, Indianapolis, IN;
4Swedish Liver Center, Department of Gastroenterology/Hepatology, Seattle, WA; 5Gilead Sciences, Inc., Foster City, CA; 6Johns Hopkins University School of Medicine, Baltimore, MD
|
|
|
|
|
|
|